fwa-executive-dashboard-2


FWA executive overview

Executive overview of anomaly dollars, provider involvement, label concentration, and CPT trouble spots.



Total claims
244,000
100% of observed claim volume

Claims with anomalies
19,500
8.0% of total claims

Total dollars
$29.28M
All claims in period

Dollars with anomalies
$5.86M
20.0% of total dollars

Providers involved
1,000
Contributing to anomaly signals

Dollar concentration curve

Shows how quickly anomaly dollars accumulate in a small number of labels.

Concentration

Labels ranked from highest to lowest anomaly dollars Top labels drive a large share

Executive takeaways

Signals that help finance prioritize follow-up.

Priority focus

Anomaly dollars are overrepresented.
Only 8.0% of claims are anomalous, yet they account for 20.0% of dollars.
High-risk providers drive the largest share.
A small provider cohort contributes disproportionately to financial exposure.
Label-level drill-down matters.
The next screen groups anomalies by label so leaders can see where effort will have the highest return.

Claims and dollars distribution

Sample CFO framing of anomaly share versus baseline claim and payment volume.

Financial lens

Metric Claims % of Claims Dollars % of Dollars
Total 244,000 100% $29,280,000 100%
With anomalies 19,500 8.0% $5,860,000 20.0%
Without anomalies 224,500 92.0% $23,420,000 80.0%

Executive takeaways

Signals that help finance prioritize follow-up.

Priority focus

Anomaly dollars are overrepresented.
Only 8.0% of claims are anomalous, yet they account for 20.0% of dollars.
High-risk providers drive the largest share.
A small provider cohort contributes disproportionately to financial exposure.
Label-level drill-down matters.
The next screen groups anomalies by label so leaders can see where effort will have the highest return.

Exposure by anomaly category

How much of the anomalous dollars sit in each risk band.

Risk mix

High risk

48%

Medium risk

36%

Low risk

16%

High-risk claims average the highest dollars per claim.
$62 avg

Priority labels

Illustrative labels to show where anomaly dollars cluster.

Label view

Pain
$2.14M anomaly dollars, 338 providers, 6,820 claims.
MSK surgery
$1.41M anomaly dollars, 126 providers, 2,940 claims.
Neurology
$930K anomaly dollars, 84 providers, 1,420 claims.
General evaluation & management
$760K anomaly dollars, 452 providers, 7,100 claims.

Reason-code themes

Common explanations that can be tied to pathway anomalies.

Explainability

Disease progression
Higher intensity services may reflect clinically plausible worsening.
Treatment progression
Additional services may follow a documented escalation ladder.
Condensed treatment pattern
Services occur too quickly or in unusual sequence relative to peers.
Other anomaly drivers
Referral loops, repeated restarts, or unusual office-visit density.

Savings opportunity

Illustrative view of where corrective action could reduce avoidable dollars.

Opportunity

High-risk labels

$2.14M in anomaly dollars.
Top CPT set

$1.77M in the ten trouble spots shown below.
Provider focus

Top 20 providers carry 58% of label dollars.
Execution path

Target label, then provider, then CPT.

Labels monitored
12
Service-area aggregation groups

Top label
Pain
Largest anomaly-dollar concentration

Top label dollars
$2.14M
36.5% of anomaly dollars

Top label providers
338
Distributed across multiple entities

Priority recommendation
Pain + MSK
Best first executive review zone

Label summary table

Aggregated anomaly exposure by service label.

Drill-ready

Label Providers Claims % Anomaly Claims Dollars % Anomaly Dollars Signal
Pain 338 6,820 35.0% $2,140,000 36.5% High
MSK surgery 126 2,940 15.1% $1,410,000 24.1% High
Neurology 84 1,420 7.3% $930,000 15.9% Medium
E&M 452 7,100 36.4% $760,000 13.0% Medium
Other 181 1,220 6.2% $620,000 10.5% Watch

How to read this page

What executives should use it for.

Decision support

Prioritize labels with high dollars and concentrated providers.
These often yield the strongest finance and investigation payoff.
Separate high-volume from high-severity.
A label can carry many claims but lower dollars, or fewer claims but higher dollar impact.
Move next into provider detail.
Once a label is chosen, the provider page shows which entities are contributing most to the exposure.

CPT trouble spots

Codes associated with the largest anomaly-dollar concentrations inside the selected label.

CPT focus

CPT Description Providers Claims Dollars Reason code
99213 Office visit, established patient 214 2,410 $612,000 Condensed treatment pattern
99214 Office visit, established patient, higher complexity 198 1,930 $540,000 Disease progression unclear
72148 MRI lumbar spine without contrast 76 1,120 $392,000 Treatment progression mismatch
64483 Injection, lumbar/sacral 54 690 $278,000 Repeat restart behavior

Actual CPT troublemakers

Direct CPT codes driving the current concentration.

CPT codes

99213 / 99214
High-volume office visits tied to repeated or condensed care patterns.
72148
Lumbar MRI appearing earlier than expected in some pathways.
64483
Injection service associated with repeated restart behavior.
97110 / 97112
Therapy codes that show up in compressed treatment sequences.

Top CPT trouble spots

Codes contributing the highest anomaly dollars in the current label set.

CPT risk

CPT Description Providers Claims Dollars % of anomaly dollars Reason code
99213 Office visit, established patient 214 2,410 $612,000 10.4% Condensed treatment pattern
99214 Office visit, established patient, higher complexity 198 1,930 $540,000 9.2% Disease progression unclear
72148 MRI lumbar spine without contrast 76 1,120 $392,000 6.7% Treatment progression mismatch
64483 Injection, lumbar/sacral 54 690 $278,000 4.7% Repeat restart behavior
97110 Therapeutic exercise 162 1,410 $210,000 3.6% Overly condensed treatment
20610 Joint injection 63 380 $188,000 3.2% Sequence deviation
62323 Injection, epidural 47 290 $174,000 3.0% Early escalation
72040 X-ray cervical spine 91 840 $158,000 2.7% Diagnosis progression gap
99204 Office visit, new patient 118 1,160 $146,000 2.5% Repeat episode restart
97112 Neuromuscular re-education 74 520 $131,000 2.2% Treatment progression mismatch

Drill down example: Pain label providers
Open
Provider concentration

Top 20 providers account for 58% of anomaly dollars inside the pain label.
Common anomaly pattern

Imaging, injections, and repeat office visits appear earlier and more densely than peer pathways.
Reason codes most common

Condensed treatment pattern, unclear progression, repeated restart of pathway.
Executive action

Select the largest provider clusters first before expanding to broad E&M review.

Selected label
Pain
Illustrative provider-level drill-down

Providers in label
338
With anomaly contribution

Top provider exposure
$384K
Highest-dollar provider in label

Top pathway reason
Condensed
Most frequent anomaly explanation

Executive next step
Escalate top 10
Bundle for focused review

Provider contribution table

Illustrative provider detail for the selected label.

Provider ranking

Provider Claims Dollars % of Label Dollars Main reason code Status
Sunrise Spine & Pain 940 $384,000 17.9% Condensed treatment pattern Escalate
Coastal Rehab Partners 810 $291,000 13.6% Treatment progression mismatch Review
Gulf Neuro Pain 602 $246,000 11.5% Disease progression not supported Review
West Bay Interventional 515 $198,000 9.3% Repeat restart behavior Watch
Harbor Ortho Group 466 $173,000 8.1% Other anomaly drivers Watch

Reason codes in context

How an executive might interpret pathway explanations.

Explainable

Disease progression
Services may intensify, but the sequence should still align with documented worsening.
Treatment progression
Escalation can be appropriate, but the step-up cadence should resemble peers in similar episodes.
Condensed treatment pattern
Services appear too tightly packed or out of expected order, suggesting a stronger review target.
Other anomaly drivers
Includes unusual revisit density, affiliate loops, or repeated episode restart patterns.

Further drill-down example: care pathway detail for Sunrise Spine & Pain
Open
Observed sequence

Office visit → MRI → injection → repeat visit → PT later than expected.
Peer sequence

Office visit → PT / conservative care → reassessment → MRI / injection if progression documented.
Reason code

Condensed treatment pattern with escalation before conservative-care completion.
Finance implication

High-dollar pathway acceleration can compound over many members and recurring restarts.